4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001209191-19-038868
Options or other derivatives
- Director acquired 26,025 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
MESSEMER DEBORAH M. · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-06-06 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +26,025 | 26,025 | D |
Loading xslF345X03/doc4.xml…